PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kathrin Jansen SVP at Pfizer to Give a Keynote Speech at GTC’s Vaccines Meeting, July 8-10, Boston - Kathrin Jansen, Senior Vice President at Pfizer, will give a keynote presentation at GTC’s 11th Vaccines Research & Development: All Things Considered Conference on July 8 10 in Boston, MA - GTCbio.com
Kathrin Jansen SVP at Pfizer to Give a Keynote Speech at GTC’s Vaccines Meeting, July 8-10, Boston

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/04/08 - Kathrin Jansen, Senior Vice President at Pfizer, will give a keynote presentation at GTC’s 11th Vaccines Research & Development: All Things Considered Conference on July 8 10 in Boston, MA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Kathrin Jansen, Senior Vice President at Pfizer will give a keynote presentation titled “A Novel Multi-antigen Vaccine to Prevent Staphylococcus Aureus Infection and Disease. Can We Beat the Bug at Its Own Game?” at GTC’s 11th Vaccines Research & Development: All Things Considered Conference on July 8 10, 2013 in Boston, MA

Staphylococcus aureus (SA) causes serious disease in both hospital and community settings and is becoming increasingly resistant to antibiotic treatment. Currently there are no prophylactic vaccines to prevent SA disease, yet the field has already experienced several vaccine failures. Learning from past experiences and taking advantage of a more recent in depth understanding of the pathogenesis mechanisms of the organism, one needs to conclude that for a prophylactic vaccine to be successful, a multi-antigen vaccine approach will be crucial. Furthermore, it is becoming increasingly clear that a vaccine must address multiple bacterial virulence mechanisms and must induce a potent antibody response that results in opsonophagocytic killing of the pathogen. To full-fill these premises, Pfizer is developing a multi-antigen vaccine composed of serotype 5 and 8 capsular polysaccharides (CP5 and CP8) conjugated to the protein carrier CRM197 and two recombinant surface-expressed protein antigens, clumping factor A (rmClfA) and manganese transporter C (MntC). The rationale for antigen selection, along with the preclinical and clinical evidence that such a vaccine candidate might be effective, will be discussed.

Kathrin Jansen has responsibility for the scientific management of vaccine research and early development and all vaccines clinical & diagnostic at Pfizer. The efforts of her group and colleagues led to the start of the Neisseria meningitides serogroup B vaccine phase 3 trials and entry into phase 1 trials for vaccines to prevent Staphylococcus aureus and Clostridium difficile disease. Dr. Jansen brings a recognized series of accomplishments, as well as an established international reputation in vaccine discovery research and development.

The 11th Vaccines Research & Development: All Things Considered Conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions on the future of the discipline.

This conference is part of our Infectious Diseases World Summit 2013 and will be held concurrently with two other tracks which are:
• 2nd Influenza Research and Development
• 10th Anti-Infectives Partnering and Deal-Making.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kathrin Jansen SVP at Pfizer to Give a Keynote Speech at GTC’s Vaccines Meeting, July 8-10, Boston

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)